Patents
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
09/2007
09/11/2007CA2163175C Anti-viral aromatic o-alkylated oximes, ethers and thioethers
09/07/2007WO2007098961A1 4, 5, 6,7-tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands
09/07/2007WO2007098923A1 Process for obtaining enantiomers of duloxetine precursors
09/07/2007WO2007098597A1 Glycosidase inhibitors and methods of synthesizing same
09/07/2007WO2007070816A3 Thiophene derivatives as factor xia inhibitors
09/07/2007CA2679271A1 Glycosidase inhibitors and methods of synthesizing same
09/07/2007CA2644439A1 Process for obtaining enantiomers of duloxetine precursors
09/07/2007CA2642813A1 Inhibitors of histone deacetylase
09/06/2007US20070208015 5-Morpholinylmethylthiophenyl Pharmaceutical Compounds As P38 MAP Kinase Modulators
09/05/2007EP1829869A1 4,5,6,7-Tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands
09/05/2007EP1829865A2 Chemical compounds
09/05/2007EP1828156A2 N-biaryl and n-arylheteroaryl piperazine derivatives as modulators of the 5ht2c receptor useful for the treatment of disorders related thereto
09/05/2007EP1373233B1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
09/05/2007CN101031564A Piperazine derivatives useful for the treatment of gastrointestinal disorders
09/05/2007CN101031539A Substituted arylalkanoic acid derivatives and use thereof
09/05/2007CN101031293A Pde4b inhibitors and uses therefor
09/05/2007CN101029051A (pyrido/thieno)-(f)-oxazepin-5-one derivatives as positive modulators of the ampa receptor
09/05/2007CN101029048A Synthesis of (2S,6R)-6-amino-2(2-thienyl)1,4-parathiazine-5-ketone
09/05/2007CN100335484C Method for preparing neutral polyethyidenedioxythiophene and its correspondent compound
09/05/2007CN100335468C Diaryl amidine compound, its production, medicinal composition and use
09/04/2007USRE39820 Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
09/04/2007US7265246 7-Aminoakyl-2-arylcarbonylaminoindanes, e.g., 3-Fluorobiphenyl-4-carboxylic acid (R)-(6-((3-ethoxypropylamino)methyl)-2R-hydroxyindan-1-yl)amide; treatment of cognitive impairment associated with schizophrenia, Alzheimer's disease, and psychoses
09/04/2007US7265163 Light emitting polymer
09/04/2007US7265130 anti-obestic activity; Neuropeptide Y antagonist
09/04/2007CA2271861C Heterocyclic metallocenes and polymerization catalysts
08/2007
08/30/2007WO2007098486A1 Crystalline forms of n-(benzo[b]thien-3-ylmethyl)-sulfamide
08/30/2007WO2007098356A1 Congeners of milnacipran as monoamine re-uptake
08/30/2007WO2007098030A1 Selective n-sulfonylation of 2-amino trifluoroalkyl substituted alcohols
08/30/2007WO2007098029A1 Methods for preparing sulfonamide substituted alcohols and intermediates thereof
08/30/2007WO2007097403A1 Remedy or preventive for digestive ulcer
08/30/2007WO2007096362A1 Heterocyclic compounds and their use in the treatment of cardiovascular disease
08/30/2007WO2007095851A1 Unsaturated 5-member heterocycle compounds, uses and preparation methods theirof
08/30/2007WO2005063734A3 Substituted thiophenes
08/30/2007US20070203341 Hybrid Organic-Inorganic Adsorbents
08/30/2007CA2643272A1 Gent for treating or preventing digestive ulcer
08/30/2007CA2643012A1 Heterocyclic compounds and their use in the treatment of cardiovascular disease
08/30/2007CA2642216A1 New crystal forms and pharmaceutical compositions of (+)-r-zileuton
08/30/2007CA2641013A1 Methods for preparing sulfonamide substituted alcohols and intermediates thereof
08/30/2007CA2637615A1 Selective n-sulfonylation of 2-amino trifluoroalkyl substituted alcohols
08/30/2007CA2634007A1 Improved synthesis and preparations of duloxetine salts
08/29/2007EP1826206A1 Sulfonium salt, curable composition, ink composition, inkjet recording method, printed material, process for producing lithographic printing plate, and lithographic printing plate
08/29/2007EP1826205A1 Novel raloxifene succinic acid addition salts and/or solvates thereof, and pharmaceutical compositions comprising these
08/29/2007EP1826204A1 Process for obtaining enantiomers of duloxetine precursors
08/29/2007EP1824836A2 2-alkyl-cycloalk(en)yl-carboxamides
08/29/2007EP1824821A2 Carbazole, carboline and indole derivatives useful in the inhibition of vegf production
08/29/2007EP1824820A2 Substituted tetracyclic tetrahydrofuran,pyrrolidine and tetrahydrothiophene derivatives
08/29/2007EP1824817A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists
08/29/2007CN101027295A Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
08/29/2007CN101024624A Oxime derivative, photopolymerisable composition, colour filter and process for producing the same
08/29/2007CN101024623A Method for synthesizing multi-substituted benzene by one reactor method
08/28/2007US7262318 Substituted heteroaryl- and phenylsulfamoyl compounds
08/28/2007US7262316 by oxidation of aromatic hydroxymethyl, aromatic alkoxymethyl and/or aromatic aldehyde compounds in the presence of acid catalyst and ammonia or ammonium salts
08/28/2007US7262310 for synthesis of a variety of medicines such as carbapenam, etc., agrochemicals and physiologically active compounds; reacting 4-halo-3-hydroxy-1-sulfonyloxybutane with sodium sulfide
08/28/2007US7262309 Cyclization at the 5,6-position of the benzo[e]naphtho[3,2-h]azulene, oxepane or thiepane with a mercaptoacetic acid ester followed by etherification, amination or sulfiding at the 2-position; antiarthritic and antiinflammatory agents, analgesics; biosynthesis inhibitors of interleukin-1
08/28/2007US7262208 Hydroxypropyl amides for the treatment of Alzheimer's disease
08/28/2007CA2210889C Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
08/23/2007WO2007095613A2 Use of benzo-heteroaryl sulfamide derivatives as neuroprotective agents
08/23/2007WO2007095200A2 A process for the preparation of (s)-(+)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine, a duloxetine intermediate
08/23/2007WO2007094200A1 Skin-whitening cosmetic
08/23/2007WO2007093439A1 Processes for the preparation of crystalline forms of duloxetine hydrochloride
08/23/2007WO2007076733A3 A METHOD FOR THE PREPARATION OF (S)-N-METΗYL-3-(l-NAPHTHYLOXY)-3-(2-THIENYL)PROPYLAMINE HYDROCHLORIDE (DULOXETINE)
08/23/2007WO2007015866A3 Inhibitors of p38 kinase and methods of treating inflammatory disorders
08/23/2007US20070197800 Selective n-sulfonylation of 2-amino flouro-and trifluoroalkyl substituted alcohols
08/23/2007US20070197789 Method of preparing thieno[3,2-c]pyridine derivatives and intermediates used therein
08/23/2007US20070197677 Sulfonium salt, curable composition, ink composition, inkjet recording method, printed material, process for producing lithographic printing plate, and lithographic printing plate
08/23/2007US20070197641 Androgen modulators
08/23/2007US20070197499 Pharmaceutical compounds
08/23/2007US20070196406 1,3-Dimethylbutyl carboxanilides for controlling undesirable micro-organisms
08/23/2007US20070194468 Method of preparing organomagnesium compounds
08/23/2007US20070194277 Light emitting polymer
08/23/2007CA2641106A1 Skin-whitening cosmetic
08/23/2007CA2640212A1 A process for the preparation of (s)-(+)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine, a duloxetine intermediate
08/22/2007EP1820800A1 Crystalline forms of duloxetine hydrochloride and processes for their preparation
08/22/2007EP1819719A2 Oligonucleotide probes
08/22/2007EP1819692A1 3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators
08/22/2007EP1819691A2 Biaryloxymethylarene carboxylic acids
08/22/2007EP1819689A1 1-alkynyl-2-aryloxyalkylamides and their use as fungicides
08/22/2007EP1742903B1 Pentenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
08/22/2007EP1687292B1 Vitamin d receptor modulators
08/22/2007CN1332958C Process for producing n-monoalkyl-3-hydroxy-3-(2-thienyl)propanamine and intermediate
08/22/2007CN101023105A Metallocene compounds, ligands used in their preparation, preparation of 1-butene polymers and 1-butene polymers therefrom
08/22/2007CN101023069A 苯甲酰基取代的丝氨酸酰胺 Benzoyl substituted serine amide
08/22/2007CN101022792A Novel compounds, pharmaceutical compositions containing same, and methods of use for same
08/22/2007CN101022727A Method for manufacturing imidazole compounds and salts and pseudopolymorphs thereof
08/22/2007CN101020654A Antitumor compound and its prepn process
08/21/2007US7259264 Reacting thiophene with 3-Chloropropionic acid chloride and with methylamine; then reducing using a microbial dehydrogenase to (1S)-3-methylamino-1-(2-thienyl)propan-1-o; chemical intermediate for (+)-(S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine oxalate
08/21/2007US7259187 Tropolone derivatives
08/21/2007US7259178 Containing an oxazole ring, e.g., 1,1,1,3,3,3-Hexafluoro-2-{4-[[5-methyl-2-(3-trifluoromethyl-phenyl)-oxazol-4-ylmethyl]-(2,2,2-trifluoro-ethyl)-amino]-phenyl}-propan-2-ol; the compounds bind to and selectively activate LXR alpha and LXR beta; used to treat diseases such as atherosclerosis and diabetes
08/21/2007US7259172 Inhibitors of β-lactamase
08/16/2007WO2007092638A1 Bicyclic sphingosine 1-phosphate analogs
08/16/2007WO2007091396A1 Novel amidopropionic acid derivative and pharmaceutical product containing same
08/16/2007WO2007090752A1 Anthranilamide/2-amino-heteroarene carboxamide derivatives
08/16/2007WO2007065261B1 Plasminogen activator inhibitor-1 inhibitors
08/16/2007WO2007026959A3 Derivatives of 4-piperazin-1-yl-4-benz0 [b] thiophene suitable for the treatment of cns disorders
08/16/2007WO2006084688A8 HIV protease inhibitors
08/16/2007US20070191616 Process for preparation of (+-)-N,N-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine, comprising racemization of (R)-N,N-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine by treatment with a base
08/16/2007US20070191472 2-(N-methyl-propanamine)-3-(2-naphthol)thiophene, an impurity of duloxetine hydrochloride
08/16/2007US20070191378 Anthranilic acid derivatives and their use as activators of the hm74a receptor
08/16/2007DE102005062661A1 Verfahren zur Herstellung von optisch aktivem (1S)-3-Chlor-(-thien-2-yl)-propan-1-ol A process for preparing optically active (1S) -3-chloro - (- thien-2-yl) -propan-1-ol
08/16/2007CA2641718A1 Bicyclic sphingosine 1-phosphate analogs
1 ... 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 ... 329